Global Lab- On-A-Chip Market, By Product (Instrument, Reagents and Consumables, Software and Others), Technology (Microarrays, microfluidics, Tissue Biochip and Others), Application (Genomics, Proteomics, Point of Care Diagnostics, Drug Discovery and Others), End-Use (Hospitals and Clinics, Biotechnology and Pharmaceuticals Companies, Forensic Laboratories, Diagnostics Centers and Academic and Research Institutes) – Industry Trends and Forecast to 2029
Market Analysis and Size
Lab-on-a-chip (LoC) combines many types of analysis such as chemical synthesis, biochemical activities, and DNA sequencing on a single chip. Miniaturization and optimization of these biochemical procedures have increased diagnostic speed and cost efficiency. Furthermore, LoC is a device capable of reducing single or several laboratory tasks down to chip-format, with chip sizes ranging from a few square centimeters to a few millimeters. Electronics, fluidics, optics, and biosensors are all integrated in LoC.
Data Bridge Market Research analyses that the lab-on-a-chip market which was USD 6.29 billion in 2021, would rocket up to USD 13.05 billion by 2029, and is expected to undergo a CAGR of 9.55% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Instrument, Reagents and Consumables, Software and Others), Technology (Microarrays, microfluidics, Tissue Biochip and Others), Application (Genomics, Proteomics, Point of Care Diagnostics, Drug Discovery and Others), End-Use (Hospitals and Clinics, Biotechnology and Pharmaceuticals Companies, Forensic Laboratories, Diagnostics Centers and Academic and Research Institutes)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Siemens (Germany), Abaxis (U.S), Danaher (U.S), Thermo Fisher Scientific Inc. (U.S), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S), Bio-Rad Laboratories Inc. (U.S), BD (U.S), PerkinElmer Inc. (U.S), Agilent Technologies Inc. (U.S) IDEX (U.S), Standard BioTools (U.S), Beckman Coulter Inc. (U.S), Illumina, Inc (U.S), LabSmith (U.S)
|
|
Market Opportunities
|
|
Market Definition
The lab-on-a-chip market is a miniature device that combines several laboratory analysis procedures into a single chip. Lap-on-chip technology is used for biochemical detection, DNA sequencing, and other applications. Chips can be as small as a few square centimeters in size and are capable of handling extremely small fluid quantities.
Lab-On-A-Chip Market Dynamics
Drivers
- Advantages of lab-on-a-chip technology
LoC technology include excellent assay sensitivity, parallelization, ergonomics, waste minimization, and others. This technology is primarily driven by the medical profession for the identification of various diseases, which aids in sample handling, provides accurate findings in a short amount of time, and serves as a market growth driver. Furthermore, in the forecast period of 2022-2029, the rise in demand for small devices, research on biosensors and biomarkers, fabrication technology, and economic feasibility will provide new opportunities for the lab-on-a-chip market.
- Rise in the chronic diseases
The integration of various disciplines and the downsizing of laboratory procedures are the hallmarks of lab-on-a-chip systems. The high level of integration required to develop LOC devices is expanding into other parts of healthcare like stem cell, drug delivery, synthetic biology, and environmental monitoring. Globally, chronic diseases are on the rise. Other factors contributing to a constant growth in frequent and costly long-term health problems include a rapidly growing global geriatric population and changes in societal behaviour. Other important factors driving the lab-on-a-chip market's growth include the use of lab-on-a-chip in the diagnosis of chronic diseases and infections.
- Usage of LoC
LoC is gaining popularity in the medical area for diagnosing various infections and disorders, including HIV infections and chronic sickness, as well as botany. This is projected to propel the market forward. Because of advantages like easy portability, automated sample processing, and re-configurability, LoC devices are in great demand. Because they deliver fast and on-time diagnosis results, LoC devices are ideal for point-of-care diagnosis.
Opportunities
Due to rising investment in research and development in pharmaceuticals, life sciences, and personalised medicine, the global lab-on-a-chip market is gaining traction. In addition, various microfluidic device makers are forming partnerships or collaborations to develop more unique lab-on-a-chip applications, propelling the industry forward. Future market growth will be fuelled by technological advancements and research into LOC miniaturisation. There are many benefits of microfluidic technologies, growing demand for diagnostics, rise in R&D investments in emerging economies, and increase in global population will provide lucrative opportunities for growth for the lab-on-chip market globally.
Restraints/Challenges
The high initial purchasing cost with lack of awareness regarding lab-on-a-chip devices among the middle income countries will act as a restrain and further challenge the growth of the lab-on-a-chip market in the forecast period mentioned above.
This lab-on-a-chip market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lab-on-a-chip market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Lab- On-A-Chip Market
The COVID-19 pandemic had a good impact on the lab-on-a-chip market, as it has raised the focus on the creation of less time-consuming diagnostic kits, and the use of the lab-on-a-chip approach in pharmaceutical R&D has expanded. Veredus Laboratories, a Singapore-based molecular diagnostics company, recently revealed the commercial availability of a portable lab-on-a-chip diagnostic tool for detecting and distinguishing 2019-nCoV, SARS CoV, and MERS-CoV. As a result, the VereCoV detection kit combines PCR and microarray technology to give high specificity, sensitivity, and a 2-hour turnaround time. As a result, health-care facilities are time-saving diagnostic techniques.
Recent Development
- In June 2020, ImmuSAFE is a lab-based biochip test that leverages Sengenics' unique KREX protein folding technology. It is a multi-antigen COVID-19 biochip test. ImmuSAFE allows researchers to identify target epitopes, titres, and Ig class/sub-class (IgG, IgA, IgM; IgG1-4) of antibodies produced at various stages of COVID-19 infection, including disease development, initial exposure, and post-recovery to post-vaccination.
Global Lab- On-A-Chip Market Scope
The lab-on-a-chip market is segmented on the basis of product type, technology, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Software
- Reagents and Consumables
- Instruments
Technology
- Microarrays
- Microfluidics
Application
- Proteomics
- Genomics
- Drug Discovery
- Diagnostics
End-user
- Diagnostic Labs
- Hospitals
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
Lab- On-A-Chip Market Regional Analysis/Insights
The lab-on-a-chip market is analysed and market size insights and trends are provided by country, product type, technology, application and end-user as referenced above.
The countries covered in the lab-on-a-chip market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America holds dominant position in the global lab-on-a-chip market.
Asia-Pacific is the fastest growing region in the global lab-on-a-chip market owing to rising population prone to viral disease.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Lab- On-A-Chip Market Share Analysis
The lab-on-a-chip market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to lab-on-a-chip market.
Some of the major players operating in the lab-on-a-chip market are:
- Siemens (Germany)
- Abaxis (U.S)
- Danaher (U.S)
- Thermo Fisher Scientific Inc. (U.S)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Abbott (U.S)
- Bio-Rad Laboratories Inc. (U.S)
- BD (U.S)
- PerkinElmer Inc. (U.S)
- Agilent Technologies Inc. (U.S)
- IDEX (U.S)
- Standard BioTools (U.S)
- Beckman Coulter Inc. (U.S)
- Illumina, Inc (U.S)
- LabSmith (U.S)
SKU-